Tenax Debt Ratio from 2010 to 2024

TENX Stock  USD 6.04  0.32  5.59%   
Tenax Therapeutics Debt Ratio yearly trend continues to be fairly stable with very little volatility. Debt Ratio will likely drop to 0.04 in 2024. During the period from 2010 to 2024, Tenax Therapeutics Debt Ratio regression line of annual values had r-squared of  0.12 and arithmetic mean of  0.11. View All Fundamentals
 
Debt Ratio  
First Reported
2010-12-31
Previous Quarter
0.04286855
Current Value
0.0407
Quarterly Volatility
0.18450832
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tenax Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tenax Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.2 K, Other Operating Expenses of 8.4 M or Research Development of 3.6 M, as well as many indicators such as Price To Sales Ratio of 141.3 K, Dividend Yield of 3.31 or PTB Ratio of 0.71. Tenax financial statements analysis is a perfect complement when working with Tenax Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Tenax Therapeutics Correlation against competitors.
For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.

Latest Tenax Therapeutics' Debt Ratio Growth Pattern

Below is the plot of the Debt Ratio of Tenax Therapeutics over the last few years. It is Tenax Therapeutics' Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tenax Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Debt Ratio10 Years Trend
Slightly volatile
   Debt Ratio   
       Timeline  

Tenax Debt Ratio Regression Statistics

Arithmetic Mean0.11
Geometric Mean0.04
Coefficient Of Variation162.33
Mean Deviation0.11
Median0.04
Standard Deviation0.18
Sample Variance0.03
Range0.7358
R-Value(0.35)
Mean Square Error0.03
R-Squared0.12
Significance0.20
Slope(0.01)
Total Sum of Squares0.48

Tenax Debt Ratio History

2024 0.0407
2023 0.0429
2021 0.18
2015 0.0356
2013 0.001072
2012 0.11
2011 0.74

Other Fundumenentals of Tenax Therapeutics

Tenax Therapeutics Debt Ratio component correlations

1.0-0.990.27-0.140.891.00.26-0.19-0.39-0.31-0.150.940.660.15-0.330.320.21-0.210.12
1.0-1.00.25-0.140.871.00.27-0.18-0.4-0.33-0.190.940.670.18-0.330.310.21-0.20.12
-0.99-1.0-0.220.1-0.85-1.0-0.280.190.390.340.2-0.93-0.63-0.210.31-0.29-0.220.2-0.1
0.270.25-0.22-0.530.390.23-0.270.60.270.450.510.170.2-0.86-0.260.540.36-0.330.42
-0.14-0.140.1-0.53-0.11-0.110.05-0.31-0.05-0.19-0.18-0.11-0.410.40.21-0.23-0.09-0.37-0.77
0.890.87-0.850.39-0.110.870.13-0.27-0.29-0.020.220.80.55-0.09-0.270.350.2-0.260.15
1.01.0-1.00.23-0.110.870.27-0.21-0.41-0.34-0.180.940.660.2-0.330.320.23-0.220.11
0.260.27-0.28-0.270.050.130.270.040.27-0.36-0.380.230.060.40.45-0.33-0.350.49-0.2
-0.19-0.180.190.6-0.31-0.27-0.210.040.630.06-0.09-0.23-0.16-0.520.090.150.08-0.070.11
-0.39-0.40.390.27-0.05-0.29-0.410.270.630.310.25-0.45-0.52-0.450.78-0.18-0.230.29-0.13
-0.31-0.330.340.45-0.19-0.02-0.34-0.360.060.310.9-0.42-0.29-0.730.160.190.11-0.10.13
-0.15-0.190.20.51-0.180.22-0.18-0.38-0.090.250.9-0.27-0.17-0.750.10.260.15-0.140.17
0.940.94-0.930.17-0.110.80.940.23-0.23-0.45-0.42-0.270.530.25-0.320.320.23-0.150.19
0.660.67-0.630.2-0.410.550.660.06-0.16-0.52-0.29-0.170.530.12-0.570.310.19-0.180.22
0.150.18-0.21-0.860.4-0.090.20.4-0.52-0.45-0.73-0.750.250.120.02-0.35-0.190.21-0.24
-0.33-0.330.31-0.260.21-0.27-0.330.450.090.780.160.1-0.32-0.570.02-0.45-0.430.55-0.26
0.320.31-0.290.54-0.230.350.32-0.330.15-0.180.190.260.320.31-0.35-0.450.96-0.640.17
0.210.21-0.220.36-0.090.20.23-0.350.08-0.230.110.150.230.19-0.19-0.430.96-0.650.08
-0.21-0.20.2-0.33-0.37-0.26-0.220.49-0.070.29-0.1-0.14-0.15-0.180.210.55-0.64-0.650.33
0.120.12-0.10.42-0.770.150.11-0.20.11-0.130.130.170.190.22-0.24-0.260.170.080.33
Click cells to compare fundamentals

About Tenax Therapeutics Financial Statements

Tenax Therapeutics investors use historical fundamental indicators, such as Tenax Therapeutics' Debt Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Tenax Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Debt Ratio 0.04  0.04 
Cash Flow To Debt Ratio(11.79)(12.38)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tenax Stock Analysis

When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.